Stoke Therapeutics, Inc. · NASDAQ:STOK
Ticho Barry sold 1,795 Stoke Therapeutics, Inc. shares (Form 4)
Traded Jun 1, 2026 · Filed Jun 3, 2026
On Jun 1, 2026, Ticho Barry (CHIEF MEDICAL OFFICER) sold 1,795 Stoke Therapeutics, Inc. shares at US$30.58 for US$54,891 under a trading plan, leaving 34,826 shares. Filed Jun 3, 2026 (Form 4).
- Sold
- 1,795 shares
- Price
- US$30.58
- Value
- US$54,891
- Holding after
- 34,826 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- CHIEF MEDICAL OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Common Stock | Sale | 1,795 | US$30.58 | 34,826 | Direct |
Source
Related
- Stoke Therapeutics, Inc.
- Ticho Barry
- Stoke Therapeutics, Inc. shareholders
- Form 4 · Ticho Barry · Oct 2, 2026
- Form 4 · Ticho Barry · Sep 3, 2026
- Form 4 · Ticho Barry · Aug 18, 2026
- Form 4 · Ticho Barry · Aug 5, 2026
- Form 4 · Ticho Barry · Jul 6, 2026
- Form 4 · Allan Jonathan · Oct 2, 2026
- Schedule 13G · Biotechnology Value Fund L P · Sep 30, 2026
- Form 4 · Kaye Edward M. MD · Aug 18, 2026
- Form 4 · Allan Jonathan · Aug 18, 2026
- Schedule 13G/A · Lynx1 Capital Management LP · Aug 14, 2026